Metraipolis › archive › dc_35d706db8108

Phase I/IIa Study of an Intravitreal Optogenetic Therapy (AGN-151597) in Patients with Advanced Retinitis Pigmentosa — Europe PMC PMID:42602510

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42602510
DOI
10.1016/j.xops.2026.101323
License (as archived)
solo-consultazione
Archived
2026-10-18T07:53:57.611Z
SHA-256 of the archived text
f62a8980c97d70e898b86d8c94e8d3acb290b5632b1aceb52c6e7d827128d4c2
Stable URL of this page
https://metraipolis.com/documento/dc_35d706db8108

How to cite

Phase I/IIa Study of an Intravitreal Optogenetic Therapy (AGN-151597) in Patients with Advanced Retinitis Pigmentosa — Europe PMC PMID:42602510 — Europe PMC (en), https://europepmc.org/article/MED/42602510 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_35d706db8108 (Metraipolis archive dc_35d706db8108, sha256 f62a8980c97d70e898b86d8c94e8d3acb290b5632b1aceb52c6e7d827128d4c2)
BibTeX
@misc{dc35d706db8108,
  title = {Phase I/IIa Study of an Intravitreal Optogenetic Therapy (AGN-151597) in Patients with Advanced Retinitis Pigmentosa — Europe PMC PMID:42602510},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42602510},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_35d706db8108; sha256 f62a8980c97d70e898b86d8c94e8d3acb290b5632b1aceb52c6e7d827128d4c2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42602510. Agents can read the archived copy with the MCP tool read_document.